NTX-1955
Phase 1- Indications
- Generalized anxiety disorder
Company intelligence / Profile preview
Longwood Fund
Boston, Massachusetts, United Stateslongwoodfund.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Longwood Fund is an active venture capital firm specializing in founding and investing in early-stage biotech and healthcare companies. Its partners have co-founded over 20 biotech firms with more than 20 launched or marketed drugs and therapies. The firm’s investments span preclinical to commercial stages across multiple therapeutic areas.
- Therapeutic areas
- OncologyPsychiatryImmunologyNeurology
- Modalities
- Small moleculeMonoclonal antibodyCell therapy
- Industry
- Investors
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Beyond the preview
Go deeper on Longwood Fund.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Longwood Fund.